140 related articles for article (PubMed ID: 12554917)
21. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients.
Kalfon P; de Vaumas C; Samba D; Boulet E; Lefrant JY; Eyraud D; Lherm T; Santoli F; Naija W; Riou B
Crit Care Med; 2007 Apr; 35(4):1032-9. PubMed ID: 17334256
[TBL] [Abstract][Full Text] [Related]
22. Hemodialysis catheters with citrate locking in critically ill patients with acute kidney injury treated with intermittent online hemofiltration or hemodialysis.
Skofic N; Buturović-Ponikvar J; Kovac J; Premru V; Knap B; Marn Pernat A; Kersnic B; Gubensek J; Ponikvar R
Ther Apher Dial; 2009 Aug; 13(4):327-33. PubMed ID: 19695069
[TBL] [Abstract][Full Text] [Related]
23. Totally implantable central venous access devices in children with hemato-oncologic malignancies: evaluation of complications and comparison of incidence of febrile episodes with similar patients without central venous access devices.
Sarper N; Zengin E; Corapçioglu F; Tugay M
Pediatr Hematol Oncol; 2006 Sep; 23(6):459-70. PubMed ID: 16849276
[TBL] [Abstract][Full Text] [Related]
24. Conversion of temporary hemodialysis catheters to permanent hemodialysis catheters: a retrospective study of catheter exchange versus classic de novo placement.
Falk A; Prabhuram N; Parthasarathy S
Semin Dial; 2005; 18(5):425-30. PubMed ID: 16191184
[TBL] [Abstract][Full Text] [Related]
25. Peripherally inserted central catheters in infants and children.
Dubois J; Garel L; Tapiero B; Dubé J; Laframboise S; David M
Radiology; 1997 Sep; 204(3):622-6. PubMed ID: 9280235
[TBL] [Abstract][Full Text] [Related]
26. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
[TBL] [Abstract][Full Text] [Related]
27. Risks and complications of prolonged parenteral antibiotic treatment in children with acute osteoarticular infections.
Ceroni D; Regusci M; Pazos JM; Saunders CT; Kaelin A
Acta Orthop Belg; 2003 Oct; 69(5):400-4. PubMed ID: 14648948
[TBL] [Abstract][Full Text] [Related]
28. Percutaneous central venous catheterisation in critically ill children.
Goh AY; Lum LC; Chan PW; Roziah M
Med J Malaysia; 1998 Dec; 53(4):413-6. PubMed ID: 10971986
[TBL] [Abstract][Full Text] [Related]
29. [Central venous access: our experience with Hickman and Broviac catheter in children].
Milanović D; Krstić Z; Vukadinović V
Srp Arh Celok Lek; 1994; 122(5-6):189-91. PubMed ID: 17977427
[TBL] [Abstract][Full Text] [Related]
30. Rate, risk factors and outcomes of catheter-related bloodstream infection in a paediatric intensive care unit in Saudi Arabia.
Almuneef MA; Memish ZA; Balkhy HH; Hijazi O; Cunningham G; Francis C
J Hosp Infect; 2006 Feb; 62(2):207-13. PubMed ID: 16307822
[TBL] [Abstract][Full Text] [Related]
31. Port-A-Cath infections in children with cancer.
Hengartner H; Berger C; Nadal D; Niggli FK; Grotzer MA
Eur J Cancer; 2004 Nov; 40(16):2452-8. PubMed ID: 15519519
[TBL] [Abstract][Full Text] [Related]
32. Survey of the use of peripherally inserted central venous catheters in neonates with critical congenital cardiac disease.
Tan LH; Hess B; Diaz LK; Cassady CI; Xu ZM; Di Chiara L; Fraser CD; Andropoulos D; Chang AC; Seidel FG
Cardiol Young; 2007 Apr; 17(2):196-201. PubMed ID: 17320005
[TBL] [Abstract][Full Text] [Related]
33. Prospective study of peripheral arterial catheter infection and comparison with concurrently sited central venous catheters.
Koh DB; Gowardman JR; Rickard CM; Robertson IK; Brown A
Crit Care Med; 2008 Feb; 36(2):397-402. PubMed ID: 18216598
[TBL] [Abstract][Full Text] [Related]
34. Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit.
Costello JM; Morrow DF; Graham DA; Potter-Bynoe G; Sandora TJ; Laussen PC
Pediatrics; 2008 May; 121(5):915-23. PubMed ID: 18450894
[TBL] [Abstract][Full Text] [Related]
35. Monthly recombinant tissue plasminogen activator administration to implantable central venous access devices decreases infections in children with haemophilia.
Jeng MR; O'Brien M; Wong W; Zoland J; Lea J; Tang N; Glader B
Haemophilia; 2009 Nov; 15(6):1272-80. PubMed ID: 19601989
[TBL] [Abstract][Full Text] [Related]
36. Short-term complications of central line placement in children with the human immunodeficiency virus.
Island ER; Church JA; Shaul DB
J Pediatr Surg; 2001 Dec; 36(12):1777-80. PubMed ID: 11733905
[TBL] [Abstract][Full Text] [Related]
37. Hickman-Broviac catheter-related infections in children with malignancies.
Stamou SC; Maltezou HC; Pourtsidis A; Psaltopoulou T; Skondras C; Aivazoglou T
Mt Sinai J Med; 1999; 66(5-6):320-6. PubMed ID: 10618732
[TBL] [Abstract][Full Text] [Related]
38. How long does it take to "rule out" bacteremia in children with central venous catheters?
Shah SS; Downes KJ; Elliott MR; Bell LM; McGowan KL; Metlay JP
Pediatrics; 2008 Jan; 121(1):135-41. PubMed ID: 18166567
[TBL] [Abstract][Full Text] [Related]
39. Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study.
Abbas AA; Fryer CJ; Paltiel C; Chedid F; Felimban SK; Yousef AA; Khattab TM
Pediatr Blood Cancer; 2004 Apr; 42(4):325-31. PubMed ID: 14966828
[TBL] [Abstract][Full Text] [Related]
40. Guidelines on the insertion and management of central venous access devices in adults.
Bishop L; Dougherty L; Bodenham A; Mansi J; Crowe P; Kibbler C; Shannon M; Treleaven J
Int J Lab Hematol; 2007 Aug; 29(4):261-78. PubMed ID: 17617077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
